Turnaround and Transformation Survey


Companies in many regions remain mired in challenges driven by the rapid rise in the cost of capital. Criticaleye Partner AlixPartners' 19th Annual Turnaround and Transformation Survey sees more than 700 of the world's restructuring experts, and executives say that the cost of capital is still the biggest factor driving company distress. However, that is just one part of the emerging story.

Key Takeaways Include:

  • Which sector globally is most likely to face distress in 2024? 
  • 82 percent expect the cost of capital to remain at current levels or increase further, while 18 percent expect it to decrease.
  • 72 percent say restructuring capital structure or moving assets is the most likely liability management technique to be activated in the next 12 months to mitigate risk.

Share this with your Community




Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.


Criticaleye Asia Podcast - Chairing for Impact: Leadership Lessons from Ray Ferguson, Global Board Chair

In this episode, Yu-Wen Hsiao, Marketing and Communications Manager, APAC at Criticaleye, speaks with Ray Ferguson, Global Board Chair and seasoned international banker, shares his perspective on how CEOs and Boards ...


Click here to download this insight

High-energy Leadership

Donal Murphy, CEO of DCC plc, has led a large-scale transformation over the last 18 months. He talks to Criticaleye's Marc Barber about why the company's future lies in energy  As a young man...


Click here to download this insight

BLOG | A Long-term View of the Business Landscape

Last week, we hosted a Leadership in the Boardroom Dinner: A Long-term View of the Business Landscape, bringing together Board members and senior executives to discuss the economic, technological and geopolitical for...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 190




British Land Mayborn Group Worldpay NatWest Group Rolls-Royce Lightsource bp Drax Group plc GlaxoSmithKline plc AlixPartners London Stock Exchange Group Canaccord Genuity Group Inc Legal & General LACE Partners Hitachi Solutions E.ON UK Aldermore Group NATS